PDCD1 and neoplasm: Tumor cells upregulate inhibitory ligands such as HLA-E, HLA-G, and PD-L1, which interact with NKG2A, KIRs, and PD-1, leading to profound suppression of NK cells cytotoxicity (12, 97).